Search

everythinglearnresearchcommunity

for

Search:↓

FFA has higher long-term remission rates than LPP.

The type of previous hair restoration surgery might affect the success of a later one, with strip harvesting possibly leading to fewer damaged hair follicles.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Both tissue expansion and serial excision are effective for scar revision in the head and neck area.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

The document concludes that specialized hair transplant techniques can be effective, with varying success rates depending on the donor area and patient factors.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Patients at dermatology specialist hospitals had lower death and readmission rates but higher treatment costs.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document says current treatments for alopecia areata do not cure or prevent it, and it's hard to judge their effectiveness due to spontaneous remission and lack of studies.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Scalp reduction surgery is safe and effective for certain patients with hair loss, leading to dense hair coverage and high satisfaction.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

Radiation cystitis patients need better monitoring and early treatment due to higher readmission rates.

Current microbial test methods for hair cosmetics need revision due to strong bacteriostasis.

The endoscopic brow lift is a safe and effective way to rejuvenate the face with a low complication rate.

The transtemporal midface lift improves the lower eyelid and cheek area with high patient satisfaction and low complication rates.